TokenPost·
Krystal Biotech Q3 Product Revenue Rises 30% to $127.3 Million
GAAP earnings per share were $2.05. Cash, cash equivalents and investments totaled $1.2 billion as of Sept. 30, 2026.
More news
- TokenPost172.7 Million Tether USDt (USDT) Moves From an Unidentified Wallet to Bitfinex
- CoinDeskNvidia, Costco and Nike join pushback against OKX–ICE tokenized stock plans
- TokenPostVanguard Target Maturity 2036 Corporate Bond ETF Sets $0.3035 Dividend
- TokenPostCrypto Liquidations Reach $176 Million, With Long Positions Leading
- Crypto BriefingMeta’s TextSeal2 improves detection of AI-generated text with new watermarking technique
- TokenPostProton CTO Says AI Is Changing Software Engineering Work